Industry News

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company will present at the Ladenburg Thalmann Healthcare Conference at the Sofitel New York Hotel on Tuesday, September 27, 2016 at 4:00 p.m. ET. EnteroMedics is a medical device company focused on the development and commercialization of its..."/>
EnteroMedics to Present at the Ladenburg Thalmann Healthcare Conference
William Demant Holding A/S has set the following dates for publication of the Company's Annual Report, Interim Report and Interim Management Statements as well as holding of the annual general meeting in 2017:. *Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 27 March 2017, a written proposal must be submitted..."/>
William Demant Holding A/S: Financial calendar 2017
Annidis Corporation, is pleased to announce that, subject to the approval of the TSX Venture Exchange, the Corporation has completed the private placement of a $500,000 unsecured promissory note with Mistarunited Technology Co., Limited a corporation directly owned and controlled by Jinsong Zhang and Chunhang Yu, directors of Annidis Corporation. The Note matures and becomes due and payable on the earlier of December 31, 2016 and the completion by the..."/>
Annidis Announces Private Placement of $500,000 Promissory Note
Aradigm Corporation announced today that it will host an Analyst Lunch on the topic of Non-Cystic Fibrosis Bronchiectasis on Monday, September 26, 2016 from 12:00 -1: 30 pm Eastern Time in New York, NY. The event will feature presentations by two key opinion leaders: David E. Griffith, MD and Gregory Tino, MD."/>
Aradigm to Host Analyst Meeting and Webcast on September 26 in New York City
Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros ®, Apricus’ novel on-demand topical cream for the treatment of erectile dysfunction, in the Czech Republic and Slovakia by Recordati. Richard Pascoe, Chief Executive Officer of Apricus, commented,“ We are pleased to announce the launch of Vitaros in these important ED markets by our partner Recordati."/>
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
ArQule, Inc. today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28 th, 2016, at 4:10 p.m. ET at the Lotte New York Palace in New York, New York. You can access the live webcast of the presentation via the“ Investors& Media” section of our website,, under“ Events&..."/>
ArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28, 2016
BioDelivery Sciences International, Inc. announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2016 Healthcare Conference. The presentation, which will be webcast, is scheduled for Tuesday, September 27, at 8:30 AM Eastern Time at the Sofitel New York in New York City."/>
BioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Allergan, a pharmaceutical company headquartered in Dublin, Ireland for an upfront cash payment of USD50m as well as success-based development, regulatory and sales milestones. In conjunction, Allergan acquires the rights to AKN-083, Akarna's lead product candidate for the potential treatment of non-alcoholic steatohepatitis and other liver diseases. AKN-083 is a small molecule, non-bile..."/>
Akarna Therapeutics Ltd buys USD50m Allergan plc
MEDNAX, Inc., a national health solutions partner specializing in neonatal and other pediatric services, anesthesiology, radiology, pediatric cardiology and other physician and management services, today announced that MEDNAX-affiliated anesthesiologist William Buhrman, M.D. was named a“ Physician of Excellence” in enhanced recovery after surgery implementation, the first U.S. anesthesiologist to receive this honor from the ERAS ® Society."/>
MEDNAX-Affiliated Anesthesiologist Receives First “Physician of Excellence” Designation in the United States by the ERAS® Society
Epizyme, Inc., a clinical-stage biopharmaceutical company creating novel epigenetic therapeutics, today announced that the Company has entered into a collaboration agreement with Foundation Medicine, Inc. to support patient identification and enrollment for Epizyme’ s ongoing Phase 2 clinical trial of tazemetostat in patients with non-Hodgkin lymphoma. Foundation Medicine’ s SmartTrials™ Precision Enrollment Program and FoundationOne..."/>
Epizyme Establishes Collaboration with Foundation Medicine to Support Tazemetostat Phase 2 Clinical Trial
Cesca Therapeutics Inc disclosed on Tuesday that it recorded a net loss from operations of USD10.9m for fiscal 2016.. This is a decrease of USD4.0m when compared with net loss from operations of USD14.9m for 2015.. The company said the reduction in net loss from operations was due to the significant decrease in overall operating expenses partially offset by a decrease in gross profit."/>
Cesca Therapeutics posts higher net loss from operations of USD10.9m for fiscal 2016
AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first quarter ended August 31, 2016, on Wednesday, October 5, 2016, before the open of the U.S. financial markets.. Management will host a conference call beginning at 8:00am E.T. on October 5 to discuss the results and to answer..."/>
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
Reliance Infrastructure files papers with Sebi for InvIT. Reliance Infrastructure Ltd has filed papers with capital market regulator Securities and Exchange Board of India to register an infrastructure investment trust for its toll road projects, Mint reported, citing two people aware of the development."/>
Deals Buzz: CCI approves acquisition of 4 Pfizer brands by Piramal Enterprises [Mint, New Delhi]
Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz ® oral soluble film and Oravig ® orally-dissolving buccal tablet. ~Partnership provides additional reach and frequency within the oncology market~~ Deal broadens Zuplenz and Oravig account call points~. ABINGDON, United Kingdom and OXFORDSHIRE, United Kingdom, Sept. 21, 2016-- Midatech Pharma, the international specialty pharmaceutical company focused on commercialising and developing..."/>
Midatech Pharma US Announces Partnership with R-Pharm US to Co-promote Zuplenz(R) (ondansetron) oral soluble film and Oravig(R) (miconazole) orally-dissolving buccal tablet
Bayer AG on Tuesday launched a mandatory open offer to buy up to 26% additional stake in Monsanto India for more than Rs.1, 100 crore, as per a stock exchange filing. Bayer said it will buy up to 4,488,315 equity shares of Monsanto India from public shareholders at Rs.2, 481.60 each, 4% above its Tuesday closing price of Rs.2, 390 on the BSE. Bayer, maker of Aspirin, Alka-Seltzer, Claritin, Coppertone sunscreen and Xarelto, last..."/>
Bayer makes offer for Monsanto India stake [Mint, New Delhi]
Community Health Systems Inc., owner of Easton Hospital, is reportedly considering putting itself up sale. Following a Bloomberg News report of the possible sale, the struggling for-profit hospital chain said Monday it's exploring a variety of options with its financial advisers. "The discussions are at a very preliminary stage and there is no timeline established for this review," CHS said in a news release."/>
Easton Hospital owner mulling sale [The Morning Call (Allentown, Pa.)]

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology772 Articles
Consumer Discretionary698 Articles
Financials540 Articles
Health Care440 Articles
Industrials435 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at